Peer-reviewedPublisher termsThe Cochrane Database of Systematic Reviews
Early erythropoiesis‐stimulating agents in preterm or low‐birthweight infants
- 1Division of Neonatology, Department of Pediatrics University of British Columbia Vancouver Canada
- 2Cochrane Neonatal Group Burlington VT USA
Related
- Health technology assessment of long-acting erythropoiesis-stimulating agents for the treatment of renal anemia in China
- Comparing Erythropoietin, Darbepoetin and No Erythropoiesis-Stimulating Agent Treatment in Preventing Anemia of Prematurity: A Multi-Center Retrospective Study
- Home visits following hospital discharge for families with preterm and low-birthweight infants.
- Elevated Anti-Cytomegalovirus IgG Levels Are Associated with Higher Erythropoiesis-Stimulating Agent Dose in Transplant-Listed Patients with End-Stage Kidney Disease
- The Association of Community Social Vulnerability and Racial Disparities with Infant Preterm Birth and Low Birthweight
BibTeX
@article{anarna2026early,
title = {{Early erythropoiesis‐stimulating agents in preterm or low‐birthweight infants}},
author = {Kia Anarna and Michelle Fiander and Souvik Mitra and Supported by the Cochrane Neonatal Group},
journal = {The Cochrane Database of Systematic Reviews},
year = {2026},
month = may,
doi = {10.1002/14651858.cd004863.pub7},
url = {https://doi.org/10.1002/14651858.cd004863.pub7},
}
RIS
TY - JOUR
TI - Early erythropoiesis‐stimulating agents in preterm or low‐birthweight infants
AU - Kia Anarna
AU - Michelle Fiander
AU - Souvik Mitra
AU - Supported by the Cochrane Neonatal Group
PY - 2026
DA - 2026/05/22
JO - The Cochrane Database of Systematic Reviews
DO - 10.1002/14651858.cd004863.pub7
UR - https://doi.org/10.1002/14651858.cd004863.pub7
SN - 1469-493X
ER -